Search for: "Merck/Schering-Plough Pharmaceuticals"
Results 41 - 60
of 69
Sort by Relevance
|
Sort by Date
25 Apr 2010, 5:52 pm
In 2005, in Schering-Plough Corp. v. [read post]
20 Apr 2010, 5:07 pm
NuvaRing, a contraceptive device marketed by Organon Pharmaceuticals and Merck & Co., has been named in some 300 product liability lawsuits. [read post]
25 Jan 2010, 5:00 am
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
28 Dec 2009, 7:57 am
Schering-Plough recently merged with Merck, and is now known as Merck & Co.California's $21.3 million agreement is one of three settlements negotiated with Schering-Plough, collectively totaling $69 million, over falsely inflated drug prices. [read post]
16 Dec 2009, 2:51 pm
Schering-Plough and Merck are each engaged in the research, development, manufacture, distribution and sale of human pharmaceutical and animal health products. [read post]
9 Nov 2009, 6:01 am
., pharmaceutical companies have been pleading guilty to criminal charges or paying penalties in civil cases when the U.S. [read post]
16 Aug 2009, 11:23 am
(Editor's Note: This post is based on a Simpson Thacher & Bartlett memorandum, which first appeared as an article in the New York Law Journal.) [read post]
12 Aug 2009, 8:09 am
(Spicy IP) UK: Hindsight going forward: taking the risk factor into account: Lilly Icos, Pfizer Enterprises, Merck, AstraZeneca & Ors v 8pm Chemists & Ors (IP finance) US: Gene patenting debate continues – round two (Patent Docs) US: Follow-on biologics news briefs – no 7 (Patent Docs) US: BIO urges Supreme Court to reject rigid Bilski rule (PatentBIOtech) US: Cargill withdraws patent infringement case before ITC against Nantong Foreign Medicines… [read post]
5 Aug 2009, 12:50 pm
· Merck/Schering-Plough’s one-minute ad for the cholesterol-lowering drug Vytorin is a standard example: it repeats the drug’s benefits over and over, but squeezes in risk information only once and just after the halfway mark. [read post]
22 Jul 2009, 12:32 pm
In fact, a 2007 piece in the New York Times suggested that Merck and Schering-Plough may have also suppressed evidence from clinical trials that found a connection between the drugs and liver problems. [read post]
17 Jun 2009, 7:59 am
Here’s how it breaks down according to the filing: JP Morgan will collect $45 million from Merck; Goldman will get up to $33.3 million from Schering-Plough and Morgan Stanley, which acted as an additional financial advisor to Schering-Plough and provided the all-important “synergies valuation” will collect $22 million. [read post]
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
20 Mar 2009, 2:20 am
The column returns to honor two lawyers behind two of the biggest, and most significant, transactions so far this year--Cooley Godward's Richard Climan advised Gilead Sciences on its $1.4 billion acquisition of CV Therapeutics, while Fried Frank's David Shine represented Merck in its $41 billion merger with Schering-Plough. [read post]
19 Mar 2009, 2:18 pm
In reality, Merck will be acquiring Schering-Plough. [read post]
8 Mar 2009, 10:48 pm
The tie-up will double the number of potential drugs Merck has in Phase III development to 18.Merck is headquartered at Whitehouse Station in NJ, and Schering-Plough is in nearby Union County. [read post]
8 Dec 2008, 12:17 pm
Recent layoffs reported in the drug industry include Sanofi (650 sales reps);Novartis (550 U.S. salespersons);Merck (8,000); Wyeth (2,440); GSK (1,000); Schering-Plough (5,500);and Boehringer Ingelheim (200). [read post]
11 Nov 2008, 5:37 pm
Vytorin is made by the drug companies Merck and Schering-Plough Pharmaceuticals. [read post]
15 Oct 2008, 11:55 am
Ed Silverman at Pharmalot reports that the City of New Haven is seeking outside counsel to sue Merck and Schering-Plough for "allegedly defective/ineffective pharmaceuticals Vytorin and Zetia," two cholesterol lowering drugs. [read post]
13 Oct 2008, 9:59 pm
Last winter, Merck and Schering-Plough were criticized for delaying the release of a study on their best-selling cholesterol medication Vytorin that showed the drug did not slow the growth of plaque in arteries. [read post]
